back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2025-08-28 10:05 Tx date 2025-08-27 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420,899
+50,772 vol $8.29 each |
7,311,914 | |
| Filed 2025-08-28 10:05 Tx date 2025-08-26 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$495,078
+59,648 vol $8.30 each |
7,261,142 | |
| Older filings | ||||||
| Filed 2025-08-25 13:25 Tx date 2025-08-22 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$493,848
+59,788 vol $8.26 each |
7,201,494 | |
| Filed 2025-08-25 13:25 Tx date 2025-08-22 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$398,864
+48,172 vol $8.28 each |
7,141,706 | |
| Filed 2025-08-25 13:25 Tx date 2025-08-20 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$578,099
+71,107 vol $8.13 each |
7,093,534 | |
| Filed 2025-08-18 13:57 Tx date 2025-08-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$68,169
+8,233 vol $8.28 each |
7,022,427 | |
| Filed 2025-08-18 13:57 Tx date 2025-08-14 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$582,323
+70,414 vol $8.27 each |
7,014,194 | |
| Filed 2025-08-18 13:56 Tx date 2025-08-13 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,389,912
+293,601 vol $8.14 each |
6,943,780 | |
| Filed 2025-07-24 11:57 Tx date 2025-07-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,999,998
+1,428,571 vol $3.50 each |
6,650,179 | |
| Filed 2024-07-03 23:24 Tx date 2024-06-28 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,000,000
+1,200,000 vol $2.50 each |
5,221,608 | |
| Filed 2023-06-28 11:24 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,999,999
+1,470,588 vol $3.40 each |
4,021,608 | |
| Filed 2023-06-28 11:24 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,551,020 | ||